Evaluation of platelet transfusion clinical trials - response to Corash & Sherman

British Journal of Haematology

Volumn 153, Issue 4, 2011, Pages 531-532

  Kerkhoffs, Jean Louis H ^a  

^a Sanquin Bloodbank   (Netherlands)

Author keywords

Clinical research; Platelets; Transfusion medicine

Indexed keywords

BLEEDING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DISEASE CLASSIFICATION; HUMAN; LETTER; PRIORITY JOURNAL; PUBLICATION; SAFETY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

EID: 79955028279     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08415.x     Document Type: Letter

References (8)

1. Davis, K.B., Slichter, S.J. & Corash, L. (1999) Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion, 39, 586-592.
2. Heddle, N.M., Cook, R.J., Sigouin, C., Slichter, S.J., Murphy, M. & Rebulla, P. (2006) A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion, 46, 903-911.
3. Kerkhoffs, J.L., van Putten, W.L., Novotny, V.M., Te Boekhorst, P.A., Schipperus, M.R., Zwaginga, J.J., van Pampus, L.C., de Greef, G.E., Luten, M., Huijgens, P.C., Brand, A. & van Rhenen, D.J. (2010) Clinical effectiveness of leukoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. British Journal of Haematology, 150, 209-217.
4. McCullough, J., Vesole, D.H., Benjamin, R.J., Slichter, S.J., Pineda, A., Snyder, E., Stadtmauer, E.A., Lopez-Plaza, I., Coutre, S., Strauss, R.G., Goodnough, L.T., Fridey, J.L., Raife, T., Cable, R., Murphy, S., Howard, F., Davis, K., Lin, J.S., Metzel, P., Corash, L., Koutsoukos, A., Lin, L., Buchholz, D.H. & Conlan, M.G. (2004) Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood, 104, 1534-1541.
5. Rebulla, P., Finazzi, G., Marangoni, F., Avvisati, G., Gugliotta, L., Tognoni, G., Barbui, T., Mandelli, F. & Sirchia, G. (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. New England Journal of Medicine, 337, 1870-1875.
6. Slichter, S.J., Kaufman, R.M., Assmann, S.F., McCullough, J., Triulzi, D.J., Strauss, R.G., Gernsheimer, T.B., Ness, P.M., Brecher, M.E., Josephson, C.D., Konkle, B.A., Woodson, R.D., Ortel, T.L., Hillyer, C.D., Skerrett, D.L., McCrae, K.R., Sloan, S.R., Uhl, L., George, J.N., Aquino, V.M., Manno, C.S., McFarland, J.G., Hess, J.R., Leissinger, C. & Granger, S. (2010) Dose of prophylactic platelet transfusions and prevention of hemorrhage. New England Journal of Medicine, 362, 600-613.
7. Snyder, E., McCullough, J., Slichter, S.J., Strauss, R.G., Lopez-Plaza, I., Lin, J.S., Corash, L. & Conlan, M.G. (2005) Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion, 45, 1864-1875.
8. Webert, K., Cook, R.J., Sigouin, C.S., Rebulla, P. & Heddle, N.M. (2006) The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica, 91, 1530-1537.